Pharma Equity Group A/S (CPH:PEG)
Denmark
· Delayed Price · Currency is DKK 0.1430
+0.0015 (1.06%)
Apr 1, 2025, 1:48 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 171.86 million as of April 1, 2025. Its market cap has decreased by -50.30% in one year.
Market Cap
171.86M
Enterprise Value
178.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 171.86M, a decrease of -77.60%. That is a compound annual growth rate of -52.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 171.86M | -26.32% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 2,104.33B |
| Coloplast | 164.64B |
| Genmab | 86.68B |
| Demant | 51.21B |
| Zealand Pharma | 39.07B |
| H. Lundbeck | 35.12B |
| Ambu A/S | 32.95B |
| ALK-Abelló | 31.74B |